Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals-Reference-Cited by-同舟云学术

Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals

Published:2016-12-10 Issue:12 Volume:2016 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Mbuagbaw Lawrence¹²,Mursleen Sara²,Irlam James H³,Spaulding Alicen B⁴,Rutherford George W⁵,Siegfried Nandi⁶⁷

Affiliation:

1. Yaoundé Central Hospital; Centre for the Development of Best Practices in Health (CDBPH); Henri Dunant Avenue PO Box 87 Yaoundé Cameroon

2. McMaster University; Department of Clinical Epidemiology and Biostatistics; Hamilton ON Canada

3. University of Cape Town; Primary Health Care Directorate; E47 OMB Groote Schuur Hospital Cape Town Western Cape South Africa 7925

4. National Institute of Allergy and Infectious Diseases; Laboratory of Clinical Infectious Diseases; 2953 TERRACE DR Bethesda MD USA 20892

5. University of California, San Francisco; Global Health Sciences; 50 Beale Street Suite 1200 San Francisco California USA 94105

6. Cape Town South Africa

7. Medical Research Council; Alcohol, Tobacco and Other Drug Research Unit; Francie van Zijl Drive Tygerberg South Africa 7505

Publisher

Wiley

Subject

Pharmacology (medical)

Reference73 articles.

1. [Nevirapine or efavirenz in combination with two nucleoside analogues in HIV-infected antiretroviral-naïve patients];Ayala Gaytán;Medicina Interna de México,2004

2. Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial;Bonnet;Lancet Infectious diseases,2013

3. Evaluation of four tenofovir-containing regimens as first-line treatments in Cameroon and Senegal: the ANRS 12115 DAYANA Trial;Landman;Antiviral Therapy,2014

4. A randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in HIV-infected patients receiving rifampicin: the N2R Study;Manosuthi;Clinical Infectious Diseases,2009

5. Mateelli A Kouanda S Saleri N Ouedraogo G Efficacy and safety of nevirapine- vs efavirenz based ART in TB/HIV patients in Burkina Faso: a clinical and pharmacokinetic study 20th Conference on Retroviruses and Opportunistic Infections. 3-16 March, 2013 Atlanta, USA 2013 Abstract 47462

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population-Specific Predictors of Immunologic Reconstitution Following Initiation of Combined Antiretroviral Therapy in Children: A Retrospective Observational Study from a 15-year Cohort of HIV-Positive Children and Adolescents in Eritrea;2024-06-19

2. Development of spectroscopic methods for assessing polymorphic content of efavirenz;Brazilian Journal of Pharmaceutical Sciences;2024

3. A retrospective observation of virologically suppressed people living with HIV by comparing switching to BIC/TAF/FTC with initial use BIC/TAF/FTC;Annals of Medicine;2023-12-12

4. Current ART, determinants for virologic failure and implications for HIV drug resistance: an umbrella review;AIDS Research and Therapy;2023-10-27

5. Current insights and molecular docking studies of HIV‐1 reverse transcriptase inhibitors;Chemical Biology & Drug Design;2023-10-10